{"nct_id":"NCT02622074","title":"Safety and Efficacy Study of Pembrolizumab (MK-3475) in Combination With Chemotherapy as Neoadjuvant Treatment for Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-173/KEYNOTE-173)","status":"COMPLETED","status_verified_date":"2020-08","start_date":"2016-01-27","start_date_type":"ACTUAL","primary_completion_date":"2018-05-31","primary_completion_date_type":"ACTUAL","completion_date":"2019-11-18","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}